Literature DB >> 15711815

[Psychosocial consequences of psoriasis--an empirical study of disease burden in 3753 affected people].

G Schmid-Ott1, P Malewski, I Kreiselmaier, U Mrowietz.   

Abstract

BACKGROUND AND
OBJECTIVE: The aim of this study was to determine the psychosocial consequences of psoriasis in a large sample in Germany. PATIENTS AND METHODS: A questionnaire including the Psoriasis Disability Index (PDI) circulated by the German Psoriasis Alliance was answered by 3753 members representing a return rate of 42.3%. Psoriasis was graded-at the time of the examination-with less than 3% of the body surface affected as "mild", between 3 and 10% as "moderate," and more than 10% as "severe."
RESULTS: The general impact of the illness on everyday life was "mild" in about 27%, "problematic" in about 45%, and "severe" in about 25% of the respondents. About 50% of the participants in the study had, concerning the skin, "mild" (PDI=9), about 35% "moderate" (PDI=14), and about 15% "severe" psoriasis (PDI=19). The differences of the PDI values are significant (ANOVA: p<0.001).
CONCLUSIONS: This investigation confirms the enormous burden caused by the skin disease in the form of impairment and stigmatization, depending on the somatic severity, even when the current affection is rather mild. In connection with psychosocial consequences, future study should also focus on the disease burden of psoriasis.

Entities:  

Mesh:

Year:  2005        PMID: 15711815     DOI: 10.1007/s00105-005-0906-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients.

Authors:  G Schmid-Ott; H W Kuensebeck; B Jaeger; T Werfel; K Frahm; J Ruitman; A Kapp; F Lamprecht
Journal:  Acta Derm Venereol       Date:  1999-11       Impact factor: 4.437

2.  Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin.

Authors:  C R Touw; L Hakkaart-Van Roijen; P Verboom; C Paul; F F Rutten; A Y Finlay
Journal:  Br J Dermatol       Date:  2001-05       Impact factor: 9.302

Review 3.  The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.

Authors:  John De Korte; Femke M C Mombers; Mirjam A G Sprangers; Jan D Bos
Journal:  Arch Dermatol       Date:  2002-09

4.  Psoriasis and stress.

Authors:  M Lebwohl; M H Tan
Journal:  Lancet       Date:  1998-01-10       Impact factor: 79.321

5.  [German instrument for the assessment of quality of life in skin diseases (DIELH). Internal consistency, reliability, convergent and discriminant validity and responsiveness].

Authors:  T Schäfer; A Staudt; J Ring
Journal:  Hautarzt       Date:  2001-07       Impact factor: 0.751

6.  [Social evaluation of skin diseases in the population. Methods and results of an informing inquiry].

Authors:  O P Hornstein; G W Brückner; U Graf
Journal:  Hautarzt       Date:  1973-06       Impact factor: 0.751

7.  The self-administered psoriasis area and severity index is valid and reliable.

Authors:  S R Feldman; A B Fleischer; D M Reboussin; S R Rapp; M L Exum; A R Clark; L Nurre
Journal:  J Invest Dermatol       Date:  1996-01       Impact factor: 8.551

8.  [Development of the German Scale for Assessing Quality of Life in Skin Diseases].

Authors:  T Schäfer; A Staudt; J Ring
Journal:  Hautarzt       Date:  2001-06       Impact factor: 0.751

9.  The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress.

Authors:  M A Gupta; A K Gupta
Journal:  Acta Derm Venereol       Date:  1995-05       Impact factor: 4.437

10.  [Stigmatization and quality of life of patients with psoriasis and atopic dermatitis].

Authors:  G Schmid-Ott; R Burchard; H H Niederauer; F Lamprecht; H-W Künsebeck
Journal:  Hautarzt       Date:  2003-07-01       Impact factor: 0.751

View more
  7 in total

1.  [Dermatologic-psychosomatic rehabilitation].

Authors:  J Wehrmann
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

Review 2.  [The educational program for the management of psoriasis vulgaris according to the rules of the Task Force on Dermatological Prevention: current status].

Authors:  T Werfel; E Breitbart; A Kleinheinz; U Gieler; G Schmid-Ott
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

3.  [The international classification of functioning, disability and health (ICF) in dermatological rehabilitation: conception, application, perspective].

Authors:  H H Niederauer; G Schmid-Ott; N Buhles
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

Review 4.  Psychoneuroimmunology: the example of psoriasis.

Authors:  J Moynihan; E Rieder; F Tausk
Journal:  G Ital Dermatol Venereol       Date:  2010-04       Impact factor: 2.011

5.  [Holistic approach to in-patient dermatological rehabilitation].

Authors:  W Gudat; W Nürnberg
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

Review 6.  German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

Authors:  A Nast; I Kopp; M Augustin; K B Banditt; W H Boehncke; M Follmann; M Friedrich; M Huber; C Kahl; J Klaus; J Koza; I Kreiselmaier; J Mohr; U Mrowietz; H M Ockenfels; H D Orzechowski; J Prinz; K Reich; T Rosenbach; S Rosumeck; M Schlaeger; G Schmid-Ott; M Sebastian; V Streit; T Weberschock; B Rzany
Journal:  Arch Dermatol Res       Date:  2007-05-12       Impact factor: 3.017

Review 7.  The German National Program on Psoriasis Health Care 2005-2015: results and experiences.

Authors:  M Augustin; L Eissing; A Langenbruch; A Enk; T Luger; D Maaßen; U Mrowietz; K Reich; M Reusch; K Strömer; D Thaçi; R von Kiedrowski; M A Radtke
Journal:  Arch Dermatol Res       Date:  2016-04-05       Impact factor: 3.017

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.